Breathe Well Live Well
|
Research and Markets: Europe Asthma Market Report – Analysis, Technologies …
Business Wire (press release) The latest research, 'Europe Asthma Market Highlights – 2015', provides asthma market analysis, competitive landscape, and asthma drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain … |
View full post on asthma – Google News
|
Dynavax Technologies Corporation (DVAX): Dynavax Initiates Phase I Trial In …
Seeking Alpha After the close of the markets on Wednesday, October 9, 2013, Dynavax (DVAX) announced it will begin dosing patients in the first human trial in its asthma program. The trial, which is being conducted under a collaborative agreement with AstraZeneca … |
View full post on asthma – Google News
|
DYNAVAX TECHNOLOGIES CORPORATION : Dynavax Initiates First Human …
4-traders (press release) BERKELEY, CA — (Marketwired) — 10/09/13 — Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the start of dosing in the first human clinical trial in its asthma program. Dynavax is conducting the trial under its collaboration agreement … Dynavax starts Phase I trial of asthma treatment Dynavax Initiates First Human Trial in Asthma Program |
View full post on asthma – Google News
|
Dynavax Technologies to commence Phase I asthma studies
Equities.com Comtex News Network. Nov 02, 2012 (Datamonitor via COMTEX) — Dynavax Technologies Corporation, a biopharmaceutical company, has announced that it will advance AZD1419, a second-generation TLR-9 agonist for asthma, into Phase I clinical studies. |
View full post on asthma – Google News
|
11 New Technologies To Manage Chronic Illness And Save Money
WBUR … asthmatic that he's driving through a known asthma-attack-inducing region and automatically switches the HVAC system to recirculate and close the windows, … The top new techs for tackling chronic diseases: report |
View full post on asthma – Google News
|
iSonea continues marketing rollout highlighting its asthma management technologies
Proactive Investors USA & Canada “This site is designed to create brand recognition and to ensure iSonea is the 'go to' company for asthma news and innovations. “It does not replace our existing corporate information website, www.iSoneaMed.com, but rather is a consumer adjunct to the … |
View full post on asthma – Google News
 Proactive Investors Australia |
iSonea continues marketing rollout highlighting its asthma management technologies
Proactive Investors Australia “This site is designed to create brand recognition and to ensure iSonea is the 'go to' company for asthma news and innovations. “It does not replace our existing corporate information website, www.iSoneaMed.com, but rather is a consumer adjunct to the … |
View full post on asthma – Google News
|
RealAge And HealthPrize Technologies Demonstrate Medication Adherence …
San Francisco Chronicle (press release) 26 at 2:40 pm The live demonstration will highlight results from the "RealAge Rewards" asthma/COPD pilot program measuring the efficacy of HealthPrize's customizable medication adherence solution on RealAge members taking a chronic medication for … |
View full post on asthma – Google News
|
Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 …
DigitalJournal.com (press release) A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory … |
View full post on asthma – Google News
|
Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 …
PR Newswire (press release) A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory … |
View full post on asthma – Google News